Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study-Reference-Cited by-同舟云学术

Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study

Published:1993-01 Issue:5 Volume:29 Page:704-708
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Paccagnella Adriano,Pappagallo Giovanni L.,Segati Romana,Zorat Pierluigi,Cavaniglia Giancarlo,Lunghi Francesco,Migliorini Vincenzo,Frattina Alberto,Bianco Antonio,Chiarion Sileni Vanna,Luciana Aversa Savina M.,Favaretto Adolfo,Vinante Orazio,Fiorentino Mario V.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Chemotherapy of recurrent and metastatic head and neck cancer;Vogl,1988

2. Head and neck cancer: chemotherapy concepts;Al Sarraf;Semin Oncol,1988

3. Treatment of recurrent (REC) or metastatics (MET) squamous cell cancer of head and neck (SCH&N) with methotrexate (M), plus diamminedichloroplatinum (D): a prospective randomized trial of the Eastern Cooperative Oncology Group;Kaplan,1981

4. A randomized prospective comparison of methotrexate with a combination of methotrexate with a combination of methotrexate, bleomycin and cisplatin in head and neck cancer;Vogl;Cancer,1985

5. Chemotherapy (CT) before locoregional treatment (LRT) in stage III + IV head and neck cancer: intermediate results of an ongoing randomized phase III trial;Paccagnella,1990

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma- A Systematic Review and Meta-Analysis;Critical Reviews in Oncology/Hematology;2020-09

2. Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma;Expert Review of Anticancer Therapy;2018-07-16

3. Impact of induction chemotherapy to concurrent chemoirradiation over radiotherapy alone in advanced oral cavity;Indian Journal of Cancer;2017

4. A Phase II Study of Weekly Paclitaxel and Epirubicin in Recurrent or Refractory Squamous Cell Carcinoma of the Head and Neck;Japanese Journal of Clinical Oncology;2008-07-11

5. Induction of apoptosis in head-and-neck squamous carcinoma cells by ?-irradiation and bleomycin is p53-independent;International Journal of Cancer;2000